Egypt Infectious Disease Market Analysis

$3,000.00$7,500.00

  • Type: Therapeutics Area
  • Published : June 2021
  • Region: Africa
  • Country: Egypt
  • Report ID : 4773

  • Format: PPT, PDF

Egypt Infectious Diseases Drug Market: Segmentation by, Drug Type (Tafenoquine, Omadacycline, Tecovirimat, Eravacycline, Delafloxacin, Plazomicin, Benznidazole, Secnidazole, Daclatasvir, Dalbavancin, Others), Mode of Action (Antibacterial Drugs, Antiviral Drugs, Antifungal Drugs, Antiparasitic Drugs), Drug Classification (Branded and Generic), Route of Administration (Oral, Parenteral, Others), Mode of Purchase (Prescription Based Drugs, Over-the-counter Drugs), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) – Growth, Trends, And Forecasts (2019 – 2028)

 Published Date: June, 2021

Clear
SKU: 4773 Categories: ,

Egypt’s Infectious diseases drugs market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Communicable diseases are contagious and chronic illnesses caused by an infectious agent, such as bacteria, viruses, fungi, or parasites. The diseases are transmitted either directly or indirectly which causes a large number of populations to get sick. Individuals affecting with any communicable diseases often experience high fever, weakness, and muscle pain

Egypt has strong vertical programs for many priority communicable diseases, such as tuberculosis and the Expanded Programme on Immunization. The action plan for the prevention, care and treatment of viral hepatitis 2014–2018 is an example of a recent strategy where the health system response was strongly emphasized in both prevention and in the care and treatment of patients.

The country is affected by a number of vector-borne diseases of public health concern. More than 30 species of mosquito have been reported, including Anopheles, Culex, Ochlerotatus (Aedes), Culiseta, and Uranotaenia. Once highly endemic and affecting large numbers, the endemicity of schistosomiasis is now low throughout the country. Rates of HIV, Malaria, and other infectious diseases also remain low in the country. It is Polio-free and large campaigns are being carried out for Hepatitis elimination. The government is also largely focused on immunization drives carried out within one year of birth.

Market Drivers

The growth of the communicable diseases treatment market (Sexually transmitted, Injection transmitted, NTD’s) creates an opportunity for the pharma companies to introduce novel therapy and promising pipeline drugs. Advances in the treatment options and the presence of well-established healthcare facilities are some of the impacting factors for the demand for drugs.

In Egypt, the Hepatitis C therapeutics market is the biggest market amongst all other infectious diseases. The COVID-19 pandemic has reignited interest in infectious diseases and the focus on infection control and treatment market through vaccination will experience tremendous growth.

Constraint Factors

Across the MENA region, the nature of diseases for which there is the most treatment demand is shifting from communicable diseases to non-communicable and chronic diseases, a shift for which multinationals are well prepared. This trend has certainly reached Egypt as life expectancy is increasing with better disease management and with improved access to healthcare, rates of lifestyle-driven and chronic diseases are decreasing.

Further, the huge financial burden and patent expiration are the factors that hinder the growth of this market.

1. Infectious Disease Drug Market Overview………………………………..
A. Market Size
2. Market Growth Drivers……………………………………………………………….
A. Rise in Communicable Diseases
B. Advancing Treatment Protocols
C. Growth due to COVID-19 Pandemic
3. Major Types of Infectious Diseases
A. HIV
B. Hepatitis
C. Tuberculosis
D. Malaria
E. Neglected tropical diseases
F. Vaccine-preventable diseases
G. Others
4. Infectious Disease Drug Market Segmentation…………………………………
A. Drug Type
I. Tafenoquine
II. Omadacycline
III. Tecovirimat
IV. Eravacycline
V. Delafloxacin
VI. Plazomicin
VII. Benznidazole
VIII. Secnidazole
IX. Daclatasvir
X. Dalbavancin
XI. Others
B. Mode of Action Type
I. Antibacterial drugs
II. Antiviral drugs
III. Antifungal drugs
IV. Antiparasitic drugs
C. Drug Classification
I. Branded Drugs
II. Generic Drugs
D. Route of Administration
I. Oral
II. Parenteral
III. Others
E. Mode of Purchase
I. Prescription-Based Drugs
II. Over-The-Counter Drugs
F. Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
5. Infectious Diseases Major Drugs Market Share……………………………..
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. Novartis overview, Product & Services, Strategies & Financials
B. EIPICO Company overview, Product & Services, Strategies & Financials
C. VASCERA Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………….
A. New Trends and Development of Infectious disease drug market
B. Future Opportunities
10. Conclusion

By Drug Type

Drug type for infectious diseases segments the market into Tafenoquine, Omadacycline, Tecovirimat, Eravacycline, Delafloxacin, Plazomicin, Benznidazole, Secnidazole, Daclatasvir, Dalbavancin, and others

By Mode of action

By mode of action, the market is segmented into Antibacterial drugs, Antiviral drugs, Antifungal drugs, and Antiparasitic drugs.

By Drug Classification

Based on the classification of drugs, the market of infectious diseases drugs has been segmented into Branded Drugs and Generic Drugs.

By Route of Administration

Based on route of administration, the infectious diseases drug market is segmented into oral, parenteral, and others.

By Mode of Purchase

Based on mode of purchase the market is segmented into prescription-based drugs and over-the-counter drugs.

By Distribution Channel

By distribution channel, the market for infectious diseases drugs in Egypt can be segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.

Major Players

Egypt’s infectious diseases treatment market appears to be fragmented with the presence of several local and global companies including EIPICO, VASCERA, Roche, AstraZeneca, Novartis, GSK, Sanofi, Pharco, Amoun, Eva Pharma, Pfizer, Hikma.

EIPICO manufactures more than 300 prescription and OTC pharmaceuticals, covering 23 therapeutic groups. It caters to the local and African markets by producing anti-parasitic drugs against infections and schistosomiasis.

In the long term, VACSERA is looking to become the top vaccine supplier in the MENA region.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements